Previous studies have shown that loss or mutation of Von Hippel-Lindau tumor suppressor (VHL) is a critical driver of ccRCC and is believed to occur at an early stage in renal cancer (100). The gene discussed is VHL; the disease is nonpapillary renal cell carcinoma.